These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2286006)

  • 1. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
    Poveda JD; Raccurt CP; Le Fur R; M'Bailara L; Malvy JM; Le Bras M; Saliou P; Fleury HJ
    Bull Soc Pathol Exot; 1990; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C; Dodin A; Wiart J
    Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous administration of hepatitis B and yellow fever vaccines.
    Yvonnet B; Coursaget P; Deubel V; Diop-Mar I; Digoutte JP; Chiron JP
    Dev Biol Stand; 1986; 65():205-7. PubMed ID: 2951287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
    Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The combined measles-yellow fever vaccination in African infants aged 6 to 10 months].
    Mouchon D; Pignon D; Vicens R; Tu-Ha-Thanh ; Tekaia F; Teulières L; Garrigue G
    Bull Soc Pathol Exot; 1990; 83(4):537-51. PubMed ID: 2286007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of anticholera vaccination on associated anti-yellow fever immunization].
    Gateff C; Le Gonidec G; Boche R; Sarrat P; Lemarinier G; Monchicourt D; Labusquière R
    Bull Soc Pathol Exot Filiales; 1973; 66(2):258-66. PubMed ID: 4801953
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience.
    Hatgi JN; Wisseman CL; Rosenzweig EC; Harrington BR; Kitaoka M
    Am J Trop Med Hyg; 1966 Jul; 15(4):601-10. PubMed ID: 5941178
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.
    Hepburn MJ; Kortepeter MG; Pittman PR; Boudreau EF; Mangiafico JA; Buck PA; Norris SL; Anderson EL
    Vaccine; 2006 Apr; 24(15):2843-9. PubMed ID: 16494976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field trial of combined yellow fever and measles vaccines among children in Nigeria.
    Adu FD; Omotade OO; Oyedele OI; Ikusika O; Odemuyiwa SO; Onoja AL
    East Afr Med J; 1996 Sep; 73(9):579-82. PubMed ID: 8991237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1987 yellow fever epidemics in Oyo State, Nigeria: a survey for yellow fever virus haemagglutination inhibiting antibody in residents of two communities before and after the epidemics.
    Olaleye OD; Omilabu SA; Faseru O; Fagbami AH
    Virologie; 1988; 39(4):261-6. PubMed ID: 2851207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arboviruses and lemurs in Madagascar: experimental infection of Lemur fulvus with attenuated strains of yellow fever virus].
    Rodhain F
    Bull Soc Pathol Exot Filiales; 1984; 77(3):255-62. PubMed ID: 6488418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous vaccination against cholera and yellow fever.
    Felsenfeld O; Wolf RH; Gyr K; Grant LS; Dutta NK
    Lancet; 1973 Mar; 1(7801):457-8. PubMed ID: 4120368
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
    Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection].
    Alvarez Vera M; Valdés Palacios D; Vázquez Ramudo S; Delgado Hernández I; García Infante S; Morier Díaz L; Guzmán Tirado MG
    Rev Cubana Med Trop; 1998; 50(3):177-81. PubMed ID: 10349439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
    Belmusto-Worn VE; Sanchez JL; McCarthy K; Nichols R; Bautista CT; Magill AJ; Pastor-Cauna G; Echevarria C; Laguna-Torres VA; Samame BK; Baldeon ME; Burans JP; Olson JG; Bedford P; Kitchener S; Monath TP
    Am J Trop Med Hyg; 2005 Feb; 72(2):189-97. PubMed ID: 15741556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.